SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-040496
Filing Date
2021-08-04
Accepted
2021-08-04 07:11:22
Documents
83
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ortx-10q_20210630.htm   iXBRL 10-Q 3607337
2 EX-10.1 ortx-ex101_12.htm EX-10.1 3426694
3 EX-31.1 ortx-ex311_6.htm EX-31.1 19288
4 EX-31.2 ortx-ex312_7.htm EX-31.2 19261
5 EX-32.1 ortx-ex321_9.htm EX-32.1 12414
  Complete submission text file 0001564590-21-040496.txt   14891258

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA ortx-20210630.xsd EX-101.SCH 66487
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ortx-20210630_cal.xml EX-101.CAL 72530
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ortx-20210630_def.xml EX-101.DEF 171289
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ortx-20210630_lab.xml EX-101.LAB 487923
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ortx-20210630_pre.xml EX-101.PRE 364587
11 EXTRACTED XBRL INSTANCE DOCUMENT ortx-10q_20210630_htm.xml XML 2083617
Mailing Address 108 CANNON STREET LONDON X0 EC4N 6EU
Business Address 108 CANNON STREET LONDON X0 EC4N 6EU 011-44-0-203-3846700
Orchard Therapeutics plc (Filer) CIK: 0001748907 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38722 | Film No.: 211142318
SIC: 2836 Biological Products, (No Diagnostic Substances)